Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Signs and Symptoms » Signs and Symptoms, Digestive » Nausea
Description
An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses. MeSH
Hierarchy View
Subtype Terms (1)
Postoperative Nausea and Vomiting
116 drugs (96 approved, 20 experimental)
Approved Indicated Drugs (27)
Phase 4 Indicated Drugs (46)
Phase 2 Indicated Drugs (26)
Phase 1 Indicated Drugs (8)
Other Experimental Indicated Drugs (26)
Organization Involved with Phase 4 Indications (97)
Algemeen Ziekenhuis Maria Middelares
Azienda Ospedaliera San Gerardo di Monza
Coastal Anesthesiology Consultants
D'Annunzio University of Chieti–Pescara
Hospital Federal de Bonsucesso
Icahn School of Medicine at Mount Sinai
Instituto do Cancer do Estado de São Paulo
Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
Pontificia Universidad Catolica de Chile
Pontificia Universidade Catolica de Sao Paulo
Second Military Medical University
The First People’s Hospital of Zunyi
Universidad Complutense de Madrid
Organization Involved with Phase 3 Indications (87)
All India Institute of Medical Sciences
Arbeitsgemeinschaft medikamentoese Tumortherapie
Canadian Institutes of Health Research (CIHR)
Hôpital Privé de Parly II - Le Chesnay
Huazhong University of Science and Technology
Instituto Mexicano del Seguro Social
Istituto Nazionale per lo Studio e la Cura dei Tumori
Mercy Medical Center, Des Moines, Iowa
National Cancer Institute (NCI)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
People's Liberation Army of China
Petrochemical General Hospital of Liaoyang city
The National Institute of Hygiene and Epidemiology, Veitnam
The Scientific and Technological Research Council of Turkey
The University of Texas, Dallas
Third People's hospital Liaoyang
University Corporation for Atmospheric Research
University of Alabama, Birmingham
University of California, San Francisco
University of North Carolina at Chapel Hill
Organization Involved with Phase 2 Indications (55)
Associazione Salentina Angela Serra
Blokhin's Russian Cancer Research Center
Center for Research and Production of Vaccines and Biologicals, Vietnam
Grady Memorial Hospital, Atlanta
Gruppo Italiano Studio Linfomi
Instituto Brasileiro de Controle do Cancer
Mashhad University of Medical Sciences
Misericordia and Dolce Hospital
National Center for Complementary and Integrative Health (NCCIH)
New Mexico Cancer Care Alliance
New York Presbyterian Hospital
Oregon Health and Science University
Pediatric Oncology Group of Ontario
Shin Nippon Biomedical Laboratories
South-Eastern Norway Regional Health Authority
Sunnybrook Health Sciences Centre
Organization Involved with Phase 1 Indications (6)
Organization Involved with Other Experimental Indications (57)
Barbara Ann Karmanos Cancer Institute
Benazir Bhutto Hospital, Rawalpindi
Faculdade de Ciências Médicas da Santa Casa de São Paulo
Harbin maternal and child health care hospital
Hegang maternal and child health care hospital
Jiamusi maternal and child health care hospital
Jixi maternal and child health care hospital
King Khaled Eye Specialist Hospital
Korea Institute of Oriental Medicine
Medical University of South Carolina
Mudanjiang maternal and child health care hospital
National Basic Research Program, China
National Research Institute of Tuberculosis and Lung Disease, Iran
Shahid Beheshti University of Medical Sciences
Silesian University of Medicine
State University of New York, Brooklyn
The Hong Kong Polytechnic University
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
